Thomas R. Diraimondo

6 Patents

• US126178652026

  Activated Antibodies Targeting PSMA and Effector Cell Antigens

  JANUX THERAPEUTICS, Inc.

  0 cites
• US124339532025

  Compositions and Methods Related to Tumor Activated Antibodies Targeting EGFR and Effector Cell Antigens

  JANUX THERAPEUTICS, Inc.

  0 cites
• US121617242024

  Compositions and Methods Related to Tumor Activated Antibodies Targeting EGFR and Effector Cell Antigens

  JANUX THERAPEUTICS, Inc.

  0 cites
• US121520262024

  Transglutaminase 2 (TG2) Inhibitors

  Sitari Pharma, Inc.

  0 cites
• US115550782023

  Compositions and Methods Related to Tumor Activated Antibodies Targeting PSMA and Effector Cell Antigens

  JANUX THERAPEUTICS, Inc.

  0 cites
• US115488922023

  Transglutaminase 2 (TG2) Inhibitors

  Sitari Pharma, Inc.

  0 cites